Henan University of Traditional Chinese Medicine
50
5
5
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 50 trials
100.0%
+13.5% vs industry average
22%
11 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (50)
Modified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation Syndrome
Role: lead
A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections
Role: lead
Disease-syndrome Characteristics of IPF
Role: lead
Idiopathic Pulmonary Fibrosis Cohort of TCM
Role: lead
Study on the Mechanism of Yifei Moxibustion Improving Immune Function in COPD Based on Plasma Exosome miRNAs
Role: lead
Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF
Role: lead
Clinical Study on Improving Exercise Capacity in Chronic Obstructive Pulmonary Disease Through Smart IoT-Remote Home Breathing Guidance
Role: lead
The Severity Assessment Model for AECOPD With Combination of Disease and Syndrome
Role: lead
Study on Acupuncture Treatment of Chronic Airway Diseases(Asthma and Chronic Obstructive Pulmonary Disease)
Role: lead
REspiratory diSEAse cohoRt Studies of CHinese Medicine for Pneumonia (RESEARCH-Pneumonia)
Role: lead
Clinical Trial of Fei Re Qing Granules in the Treatment of Elderly Community-Acquired Pneumonia
Role: lead
Effect of Traditional Chinese Medicine of Severe COVID-19
Role: lead
Clinical Study on the Treatment of Chronic Airway Diseases (Asthma, Chronic Obstructive Pulmonary Disease) with Shu Fei Tie
Role: lead
Research on the Characteristics of Chronic Airway Diseases (asthma, COPD)
Role: lead
Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD
Role: lead
Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese Medicine
Role: lead
Lifei Xiaoji Wan in Treatment of Advanced NSCLC
Role: lead
Respiratory Disease Cohort Studies of Chinese Medicine for COPD(RESEARCH-COPD)
Role: lead
REspiratory diSEAse cohoRt Studies of CHinese Medicine for ILD (RESEARCH-ILD)
Role: lead
Exhaled Breath Condensate Biomarkers in CARAS
Role: lead